Morphine in combination with metabotropic glutamate receptor antagonists on schedule-controlled responding and thermal nociception

Journal of Pharmacology and Experimental Therapeutics

Volumn 324, Issue 2, 2008, Pages 732-739

  Fischer, Bradford D ^a,c   Zimmerman, Eric I ^b   Picker, Mitchell J ^a   Dykstra, Linda A ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3,4 DIHYDRO 2H PYRANO [2,3 B]QUINOLIN 7 YL (4 METHOXYCYCLOHEXY)METHANONE]; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 5; JNJ 16259685; METABOTROPIC RECEPTOR ANTAGONIST; MORPHINE; UNCLASSIFIED DRUG;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; TEMPERATURE SENSE; TEMPERATURE STRESS; THERMAL STIMULATION;

ANIMALS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; HEAT; MALE; MICE; MICE, INBRED C57BL; MORPHINE; PAIN; PAIN MEASUREMENT; RECEPTORS, METABOTROPIC GLUTAMATE; REINFORCEMENT SCHEDULE;

EID: 38749131191     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.131417     Document Type: Article

References (41)

1. Alvarez FJ, Villalba RM, Carr PA, Grandes P, and Somohano PM (2000) Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord. J Comp Neurol 422:464-487.
2. Bond A and Lodge D (1995) Pharmacology of metabotropic glutamate receptor-mediated enhancement of responses to excitatory and inhibitory amino acids on rat spinal neurones in vivo. Neuropharmacology 34:1015-1023.
3. Bossard AE, Guirimand F, Fletcher D, Gaude-Joindreau V, Chauvin M, and Bouhassira D (2002) Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain 98:47-57.
4. Cao CQ, Evans RH, Headley PM, and Udvarhelyi PM (1995) A comparison of the effects of selective metabotropic glutamate receptor agonists on synaptically evoked whole cell currents of rat spinal ventral horn neurones in vitro. Br J Pharmacol 115:1469-1474.
5. Carlton SM, Hargett GL, and Coggeshall RE (2001) Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 105:957-969.
6. Cerne R and Randic M (1992) Modulation of AMPA and NMDA responses in rat spinal dorsal horn neurons by trans-1-aminocyclopentane-1,3-dicarboxylic acid. Neurosci Lett 144:180-184.
7. Craft RM and Lee DA (2005) NMDA antagonist modulation of morphine antinociception in female vs. male rats. Pharmacol Biochem Behav 80:639-649.
8. Fischer BD, Carrigan KA, and Dykstra LA (2005) Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. J Pain 6:425-433.
9. Fischer BD and Dykstra LA (2006) Interactions between an NMDA antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception. J Pharmacol Exp Ther 318:1300-1306.
10. Fundytus ME, Yashpal K, Chabot JG, Osborne MG, Lefebvre CD, Dray A, Henry JL, and Coderre TJ (2001) Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats. Br J Pharmacol 132:354-367.
11. Galer BS, Lee D, Ma T, Nagle B, and Schlagheck TG (2005) MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain 115:284-295.
12. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, Biollaz M, Allgeier H, Heckendorn R, Urwyler S, et al. (1999) 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38:1493-1503.
13. Grabovsky Y and Tallarida RJ (2004) Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther 310:981-986.
14. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
15. Jeziorski M, White FJ, and Wolf ME (1994) MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse 16:137-147.
16. Jia H, Rustioni A, and Valtschanoff JG (1999) Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J Comp Neurol 410:627-642.
17. Jones CK, Eberle EL, Peters SC, Monn JA, and Shannon HE (2005) Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing. Neuropharmacology 49:206-218.
18. Kelso SR, Nelson TE, and Leonard JP (1992) Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J Physiol 449:705-718.
19. King AE and Liu XH (1996) Dual action of metabotropic glutamate receptor agonists on neuronal excitability and synaptic transmission in spinal ventral horn neurons in vitro. Neuropharmacology 35:1673-1680.
20. Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Belagaje R, Wu S, and Schoepp DD (1998) LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37:1-12.
21. Klodzinska A, Chojnacka-Wojcik E, Palucha A, Branski P, Popik P, and Pilc A (1999) Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology 38:1831-1839.
22. Kozela E, Pilc A, and Popik P (2003) Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology 165:245-251.
23. Lavreysen H, Wouters R, Bischoff F, Nobrega Pereira S, Langlois X, Blokland S, Somers M, Dillen L, and Lesage AS (2004) JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist. Neuropharmacology 47:961-972.
24. Loewe S (1953) The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3:285-290.
25. Naisbitt S, Kim E, Tu JC, Xiao B, Sala C, Valtschanoff J, Weinberg RJ, Worley PF, and Sheng M (1999) Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23:569-582.
26. Nemmani KV, Grisel JE, Stowe JR, Smith-Carliss R, and Mogil JS (2004) Modulation of morphine analgesia by site-specific N-methyl-D- aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time. Pain 109:274-283.
27. Neugebauer V (2002) Metabotropic glutamate receptors: important modulators of nociception and pain behavior. Pain 98:1-8.
28. Papp M, Gruca P, and Willner P (2002) Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist. Neuropsychopharmacology 27:727-743.
29. Pin JP and Duvoisin R (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34:1-26.
30. Popik P, Kozela E, and Pilc A (2000) Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. Br J Pharmacol 130:1425-1431.
31. Popik P and Wrobel M (2002) Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 43:1210-1217.
32. Skeberdis VA, Lan J, Opitz T, Zheng X, Bennett MV, and Zukin RS (2001) mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 40:856-865.
33. Smith FL, Smith PA, Dewey WL, and Javed RR (2004) Effects of mGlu1 and mGlu5 metabotropic glutamate antagonists to reverse morphine tolerance in mice. Eur J Pharmacol 492:137-142.
34. Stevenson GW, Folk JE, Rice KC, and Negus SS (2005) Interactions between δ and μ opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(αR)-α- ((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl] -N,N-diethylbenzamide] and heroin. J Pharmacol Exp Ther 314:221-231.
35. Tallarida RJ (2000) Drug Synergism and Dose-Effect Data Analysis, Chapman & Hall/CRC Press, Boca Raton, FL.
36. Trujillo KA and Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87.
37. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P, Doan A, Aakalu VK, Lanahan AA, Sheng M, et al. (1999) Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23:583-592.
38. Varty GB, Grilli M, Forlani A, Fredduzzi S, Grzelak ME, Guthrie DH, Hodgson RA, Lu SX, Nicolussi E, Pond AJ, et al. (2005) The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology 179:207-217.
39. Vidnyanszky Z, Hamori J, Negyessy L, Rüegg D, Knöpfel T, Kuhn R, and Gorcs TJ (1994) Cellular and subcellular localization of the mGluR5a metabotropic glutamate receptor in rat spinal cord. NeuroReport 6:209-213.
40. Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, et al. (2001) Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function: I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology 40:1-9.
41. Yoon MH, Choi J, Bae HB, Kim SJ, Chung ST, Jeong SW, Chung SS, Yoo KY, and Jeong CY (2006) Antinociceptive effects and synergistic interaction with morphine of intrathecal metabotropic glutamate receptor 2/3 antagonist in the formalin test of rats. Neurosci Lett 394:222-226.